Collaborate Disseminate
The World Health Organization (WHO) has declared the global monkeypox outbreak a Public Health Emergency of International Concern (PHEIC). The outbreak has now spread to 75 countries with more than 16,000 cases officially recorded.Continue ReadingCateg… Continue reading Monkeypox declared global health emergency, 72 child cases reported
Researchers at MIT have developed microparticles that can release doses of drugs at specific times over days, weeks or months. The platform could be useful for creating what the team calls “self-boosting vaccines.”Continue ReadingCategory: Medical, Sci… Continue reading “Self-boosting vaccines” load multiple drug doses into a single shot
After months of delays the US Food and Drug Administration (FDA) has finally issued an emergency use authorization (EUA) for the Novavax COVID-19 vaccine. Once doses are available this will be the first protein-based COVID vaccine authorized in the Uni… Continue reading FDA finally authorizes Novavax COVID-19 vaccine in US
With the Omicron subtype BA.5 rapidly becoming dominant in the United States a small body of research has begun to reveal the unique properties of this novel SARS-CoV-2 variant. Two recent preprints have described how BA.5 is more immune-evasive than p… Continue reading Does BA.5 cause more severe disease than earlier Omicron subvariants?
As scientists frantically chase a rapidly mutating SARS-CoV-2 virus by trying to update current COVID vaccines to better target circulating variants, a huge project is bubbling away in the background. The goal is to create a universal coronavirus vacci… Continue reading Another universal coronavirus vaccine readies for human trials
More than 18 months ago a global COVID-19 vaccine roll-out commenced, beginning the biggest international immunization campaign seen in decades. Since then, the virus that causes COVID-19 has mutated significantly and health authorities have been discu… Continue reading FDA and WHO disagree on COVID-19 vaccine booster variant advice
Researchers at the National Institutes of Health (NIH) are beginning a Phase 1 human trial to test a new universal flu vaccine. The trial will test the novel vaccine being delivered either as a nasal spray or by injection after animal studies demonstra… Continue reading Universal flu vaccine developed by US government begins human trials
Biotech company Novavax has revealed its COVID-19 vaccine can generate effective immune responses against all circulating Omicron variants. The unexpected data was delivered to an advisory panel convened by the US Food and Drug Administration (FDA) to … Continue reading Novavax COVID vaccine surprisingly effective against all Omicron variants
A large new study tracking the health of around two million people has found annual influenza vaccination is associated with a significantly lower risk of developing Alzheimer’s disease. The compelling findings build on growing research finding links between several viral infections and neurodegenerative disease.
Category: Science
Tags: Virus, Brain, Influenza, Vaccines, The Immune System, Alzheimer’s Disease, Dementia
Continue reading How the flu vaccine can lower the risk of Alzheimer’s disease
New modeling from researchers at Imperial College London has estimated COVID-19 vaccines prevented nearly 20 million deaths worldwide in 2021. The study also concluded millions more lives could have been saved last year if vaccine distribution was more… Continue reading Study estimates COVID vaccines saved nearly 20 million lives last year